Skip to content

A study on excision margin of breast-conserving surgery in breast cancer patients undergone neoadjuvant chemotherapy

A study on excision margin of breast-conserving surgery in breast cancer patients undergone neoadjuvant chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014663
Enrollment
Unknown
Registered
2018-01-28
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Group 1:Mark the tumor and the original tumor bed before NAC using tissue markers (one clip at the center and other four clips at 4 edges). Conduct BCS per the original tumor bed (where the markers ar
Group 2:Mark the tumor with the tissue marker (1 clip at the center) before NAC. After NAC, conduct BCS per the residual tumor bed.

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The tumor is >= 3cm in diameter, and determined to be unicentric lesion by mammary MRI; 2. The subject desires BCS; 3. The resection margins are pathologically negative; 4. The subject achieved CR or PR after NAC by clinical evaluation; 5. Without absolute contraindications of BCS; 6. Provide informed consent.

Exclusion criteria

Exclusion criteria: 1. The subject refused BCS before or after NAC; 2. The subject was clinically evaluated as SD or PD after NAC; 3. Detected local or distant neo lesion in pre-operative evaluation after NAC; 4. The resection margin or margins are pathologically positive; 5. Multicentric lesion; 6. With a medical history of malignant tumor; 7. Tumor infiltrated chest wall or skin, or inflammatory breast cancer; 8. With absolute contraindications as per the NCCN guideline; 9. Supraclavicular lymph nodes metastasis.

Design outcomes

Primary

MeasureTime frame
Exploration of tumor cells in primary tumor bed;Ipsilateral breast tumor recurrence (IBTR);The positive rates of margins of breast-conserving surgery identified by postoperative pathological examination;

Secondary

MeasureTime frame
Local regional recurrence (LRR), including ipsilateral breast recurrence, chest wall/skin recurrence and ipsilateral axillary/supraclavicular/internal mammory lymph node recurrence;Distant metastasis;Disease-free survival (DFS);Overall survival (OS);

Countries

China

Contacts

Public ContactGuosheng Ren, Hongyuan Li, Xuedong Yin

The First Affiliated Hospital of Chongqing Medical University

rgs726@163.com+86 13508370536

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026